Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections.

Journal of managed care pharmacy : JMCP

Volumn 9, Issue 4, 2003, Pages 317-326

  Parodi, Stephen ^a   Rhew, David C ^a   Goetz, Matthew Bidwell ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; LINEZOLID; OXAZOLIDINONE DERIVATIVE; VANCOMYCIN;

AGED; ARTICLE; ECONOMICS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PENICILLIN RESISTANCE; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ACETAMIDES; ADMINISTRATION, ORAL; AGED; ANTI-INFECTIVE AGENTS; FEMALE; HOSPITALS, VETERANS; HUMANS; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; LOS ANGELES; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; OXAZOLIDINONES; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 0348118361     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2003.9.4.317     Document Type: Article

References (0)